Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-24-009543

Chief Scientific Officer gave up 2,709 shares (to pay taxes)

  • Chief Scientific Officer acquired 5,860 shares (grant or award)
  • Chief Scientific Officer acquired 9,275 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-30 Exercise or conversion : show line 1 in the form +9,275 29,699 D
2024-01-30 Shares withheld for taxes : show line 2 in the form −2,709 $9.80 $26,548 26,990 D
2024-01-31 Grant or award : show line 3 in the form +5,860 $2.69 $15,763 32,850 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-30 Exercise or conversion : show line 4 in the form Restricted Stock Units −9,275 27,825 D
Loading xslF345X05/tm244961-5_4seq1.xml…